Investing Profile
Matthew De Silva
Your Intro Paths to Matthew De Silva
Signal uses Gmail to reveal intro paths. Email content is never read.
Sign in with Google →Networks Matthew is a member of
Cornell University Network
384 CONNECTIONS
BofA Securities Network
171 CONNECTIONS
Builders VC Network
15 CONNECTIONS
Clarium Capital Management Network
13 CONNECTIONS
Find Matthew De Silva on
cbCurrent Investing Position
Builders VC Venture Partner
Investment Range
$100K - $5.0M
Sweet Spot
$1.5M
Investments On Record
3
Matthew De Silva is on these Sector & Stage Rankings
Matthew De Silva's Investments On Record (3)
| Company | StageDateRound Size | Total Raised |
|---|---|---|
Eigen Therapeutics | SeedDec 2022$7M | $7M |
Arpeggio Bio | Series ASep 2022$17M | $20M |
Enveda Biosciences | Series AJun 2021$51M | $500M |
Matthew De Silva's Experience
Intern Moore Capital ManagementPresent
Analyst BofA SecuritiesPresent
Portfolio Manager Clarium Capital ManagementPresent
Advisor and Angel Investor ENDPOINT HEALTHPresent
Angel Investor & Syndicate Lead Longtail Health VenturesPresent
Chief Operating Officer PathosPresent
Founder and CEO NotablePresent
Founder & Executive Chairman NotablePresent
Venture Partner Builders VCPresent
Matthew De Silva's Education
Cornell University B.S. Applied Economics & Management
Investors who invest with Matthew De Silva
Sign in with Google →Scouts & Angels Affiliated With Matthew De Silva
Sign in with Google →